Alvotech (ALVO)
4.89
+0.03
(+0.62%)
USD |
NASDAQ |
Nov 09, 09:39
Alvotech Total Assets (Quarterly) : 1.587B for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.587B |
| March 31, 2026 | 1.421B |
| December 31, 2025 | 1.487B |
| September 30, 2025 | 1.409B |
| June 30, 2025 | 1.393B |
| March 31, 2025 | 1.245B |
| December 31, 2024 | 1.221B |
| September 30, 2024 | 1.233B |
| June 30, 2024 | 1.068B |
| March 31, 2024 | 1.061B |
| December 31, 2023 | 950.09M |
| September 30, 2023 | 958.82M |
| Date | Value |
|---|---|
| June 30, 2023 | 910.66M |
| March 31, 2023 | 895.46M |
| December 31, 2022 | 828.44M |
| September 30, 2022 | 683.13M |
| June 30, 2022 | |
| March 31, 2022 | 250.69M |
| December 31, 2021 | 250.72M |
| September 30, 2021 | 251.08M |
| June 30, 2021 | 251.18M |
| March 31, 2021 | 251.37M |
| December 31, 2020 | 251.53M |
| September 30, 2020 | 252.29M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agenus, Inc. | 245.55M |
| Amgen, Inc. | 96.05B |
| Regeneron Pharmaceuticals, Inc. | 44.41B |
| Anika Therapeutics, Inc. | 189.60M |
| BioCryst Pharmaceuticals, Inc. | 591.07M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.779B |
| Shareholders Equity (Quarterly) | -191.48M |
| Debt to Equity Ratio | -7.582 |
| Current Ratio | 1.646 |
| Net Debt Paydown Yield | -3.42% |